US Bancorp DE Reduces Align Technology Stake

Institutional investor sells nearly 10,000 shares of medical equipment provider

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

US Bancorp DE, a major institutional investor, reduced its position in Align Technology, Inc. (NASDAQ:ALGN) by 13.5% in the third quarter of 2025. The firm sold 9,880 shares, leaving it with 63,241 shares worth $7.9 million in the medical equipment provider known for its Invisalign clear aligners.

Why it matters

Align Technology has seen its stock price fluctuate in recent quarters as the company navigates industry challenges. This sale by a prominent institutional investor provides insight into how some major players are viewing the stock's performance and future prospects.

The details

According to a regulatory filing, US Bancorp DE sold 9,880 shares of Align Technology in the third quarter, reducing its total stake to 63,241 shares. The firm cited the medical equipment provider's stock performance as the reason for the sale. Align Technology's share price has ranged from a 52-week low of $122 to a high of $208.30 over the past year.

  • The share sale occurred in the third quarter of 2025.

The players

US Bancorp DE

A major institutional investor that reduced its stake in Align Technology.

Align Technology, Inc.

A medical equipment provider known for its Invisalign clear aligner products.

Got photos? Submit your photos here. ›

The takeaway

This transaction highlights the volatility in Align Technology's stock price and the cautious approach some institutional investors are taking with the company's shares amid industry challenges.